Rutosides for prevention of post-thrombotic syndrome.

Cochrane Database Syst Rev 2018 11 8;11:CD005626. Epub 2018 Nov 8.

Division of Epidemiology and Public Health, University of Nottingham, C120, Clinical Sciences Building - Ph2, City Hospital Campus, Hucknall Road, Nottingham, UK, NG5 1PB.

Background: Post-thrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT) that is characterised by pain, swelling, and skin changes in the affected limb. One in three patients with DVT will develop post-thrombotic sequelae within five years. The current standard care for the prevention of PTS following DVT is elastic compression stockings. Rutosides are a group of compounds derived from horse chestnut (Aesculus hippocastanum), a traditional herbal remedy for treating oedema formation in chronic venous insufficiency (CVI). However, it is not known whether rutosides are effective and safe in the prevention of PTS. This is the second update of the review first published in 2013.

Objectives: To determine the effectiveness and safety of rutosides for prevention of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis (DVT), compared to placebo, no intervention, or reference medication.

Search Methods: The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 21 August 2018.

Selection Criteria: We planned to include trials of rutosides versus any alternative (placebo, no intervention, or reference medication) in the prevention of PTS in patients with DVT.

Data Collection And Analysis: Two review authors independently assessed studies for inclusion and intended to extract information from the trials.

Main Results: No studies were identified comparing rutosides versus any alternative in the prevention of PTS.

Authors' Conclusions: As there were no studies identified in this review there is currently insufficient evidence to determine the effectiveness and safety of rutosides for prevention of PTS in patients with DVT. Some studies suggest that rutosides may provide short-term relief of PTS symptoms. However, there is nothing published on their use as a preventative therapy for PTS. High quality randomised controlled trials of rutoside versus any alternative are required to build the evidence base in this area.

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD005626.pub4
Publisher Site
http://dx.doi.org/10.1002/14651858.CD005626.pub4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516967PMC
November 2018

Publication Analysis

Top Keywords

prevention pts
16
pts patients
12
versus alternative
12
post-thrombotic syndrome
12
rutosides prevention
12
placebo intervention
8
rutosides versus
8
thrombosis dvt
8
rutosides
8
patients dvt
8
cochrane vascular
8
studies identified
8
intervention reference
8
effectiveness safety
8
syndrome pts
8
prevention post-thrombotic
8
safety rutosides
8
determine effectiveness
8
pts
8
prevention
6

Similar Publications

Rutosides for prevention of post-thrombotic syndrome.

Cochrane Database Syst Rev 2015 Sep 16(9):CD005626. Epub 2015 Sep 16.

Centre for Population Health Sciences, University of Edinburgh, Medical Buildings, Teviot Place, Edinburgh, UK, EH8 9AG.

Background: Post-thrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT) that is characterised by pain, swelling, and skin changes in the affected limb. One in three patients with DVT will develop post-thrombotic sequelae within five years. The current standard care for the prevention of PTS following DVT is elastic compression stockings. Read More

View Article and Full-Text PDF
September 2015

Rutosides for treatment of post-thrombotic syndrome.

Cochrane Database Syst Rev 2018 11 8;11:CD005625. Epub 2018 Nov 8.

Division of Epidemiology and Public Health, University of Nottingham, C120, Clinical Sciences Building - Ph2, City Hospital Campus, Hucknall Road, Nottingham, UK, NG5 1PB.

Background: Post-thrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT) that is characterised by pain, swelling, and skin changes in the affected limb. One in three patients with DVT will develop post-thrombotic sequelae within five years. Rutosides are a group of compounds derived from horse chestnut (Aesculus hippocastanum), a traditional herbal remedy for treating oedema formation in chronic venous insufficiency (CVI). Read More

View Article and Full-Text PDF
November 2018

Rutosides for prevention of post-thrombotic syndrome.

Cochrane Database Syst Rev 2013 Apr 30(4):CD005626. Epub 2013 Apr 30.

Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.

Background: Post-thrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT) that is characterised by pain, swelling, and skin changes in the affected limb. One in three patients with DVT will develop post-thrombotic sequelae within five years. The current standard care for the prevention of PTS following DVT is elastic compression stockings. Read More

View Article and Full-Text PDF
April 2013

Rutosides for treatment of post-thrombotic syndrome.

Cochrane Database Syst Rev 2015 Sep 16(9):CD005625. Epub 2015 Sep 16.

Centre for Population Health Sciences, University of Edinburgh, Medical Buildings, Teviot Place, Edinburgh, UK, EH8 9AG.

Background: Post-thrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT) that is characterised by pain, swelling, and skin changes in the affected limb. One in three patients with DVT will develop post-thrombotic sequelae within five years. Rutosides are a group of compounds derived from horse chestnut (Aesculus hippocastanum), a traditional herbal remedy for treating oedema formation in chronic venous insufficiency (CVI). Read More

View Article and Full-Text PDF
September 2015